| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology and Genetics |
Department of Medicine, Division of Gastroenterology [Y. X., F. M. S., J. Y., T. T. Z., V. S., Y. M., F. S., T. C. L., A. O., S. W., M. C. K., K. D., B. D. G., J. M. A., S. J. M.], Department of Surgery, Division of Thoracic Surgery [M. J. K.], and Department of Surgical Oncology [K. P., D. S.], Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore VA Hospital, Baltimore, Maryland 21201
cDNAmicroarrays, combined with bioinformatics analyses, are becomingincreasingly used in current medical research. Existing analytic methods,particularly those that are unsupervised, often have difficulty recognizing subtle differences among predefined subgroups. In contrast, supervised methods, such as Artificial Neural Networks (ANNs), are able to recognize subtly different biological entities. We applied ANNs in a proof-of-principle study of cDNA microarray data in esophageal cancer (CA) and premalignancy. cDNA microarrays, each containing 8064 clones, were hybridized to RNAs from 22 esophageal lesions, including 14 Barretts esophagus (BA) metaplasias and 8 esophageal carcinomas (3 squamous cell carcinomas and 5 adenocarcinomas). Scanned cDNA microarray data were analyzed using the bioinformatics software Cluster/TreeView, Significance Analysis of Microarrays (SAM), and ANNs. Cluster analysis based on all 8064 clones on the microarrays was unable to correctly distinguish BA specimens from CA specimens. SAM then selected 160 differentially expressed genes between Barretts and cancer. Cluster analysis based on this reduced set still misclassified 2 Barretts as cancers. The ANN was trained on 12 samples and tested against the remaining 10 samples. Using the 160 selected genes, the ANN correctly diagnosed all 10 samples in the test set. Finally, the 160 genes selected by SAM may merit further study as biomarkers of neoplastic progression in the esophagus, as well as in elucidating pathological mechanisms underlying BA and CA.
This article has been cited by other articles:
![]() |
E. Sabo, P. A. Meitner, R. Tavares, C. L. Corless, G. Y. Lauwers, S. F. Moss, and M. B. Resnick Expression Analysis of Barrett's Esophagus-Associated High-Grade Dysplasia in Laser Capture Microdissected Archival Tissue Clin. Cancer Res., October 15, 2008; 14(20): 6440 - 6448. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Chung, T. Braunschweig, N. Hu, M. Roth, J. L. Traicoff, Q.-H. Wang, V. Knezevic, P. R. Taylor, and S. M. Hewitt A multiplex tissue immunoblotting assay for proteomic profiling: a pilot study of the normal to tumor transition of esophageal squamous cell carcinoma. Cancer Epidemiol. Biomarkers Prev., July 1, 2006; 15(7): 1403 - 1408. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Luthra, T.-T. Wu, M. G. Luthra, J. Izzo, E. Lopez-Alvarez, L. Zhang, J. Bailey, J. H. Lee, R. Bresalier, A. Rashid, et al. Gene Expression Profiling of Localized Esophageal Carcinomas: Association With Pathologic Response to Preoperative Chemoradiation J. Clin. Oncol., January 10, 2006; 24(2): 259 - 267. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Talbot, C. Estilo, E. Maghami, I. S. Sarkaria, D. K. Pham, P. O-charoenrat, N. D. Socci, I. Ngai, D. Carlson, R. Ghossein, et al. Gene Expression Profiling Allows Distinction between Primary and Metastatic Squamous Cell Carcinomas in the Lung Cancer Res., April 15, 2005; 65(8): 3063 - 3071. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. T. Kimchi, M. C. Posner, J. O. Park, T. E. Darga, M. Kocherginsky, T. Karrison, J. Hart, K. D. Smith, J. J. Mezhir, R. R. Weichselbaum, et al. Progression of Barrett's Metaplasia to Adenocarcinoma Is Associated with the Suppression of the Transcriptional Programs of Epidermal Differentiation Cancer Res., April 15, 2005; 65(8): 3146 - 3154. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Helm, S. A. Enkemann, D. Coppola, J. S. Barthel, S. T. Kelley, and T. J. Yeatman Dedifferentiation Precedes Invasion in the Progression from Barrett's Metaplasia to Esophageal Adenocarcinoma Clin. Cancer Res., April 1, 2005; 11(7): 2478 - 2485. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Takahashi, T. Kobayashi, and H. Honda Construction of robust prognostic predictors by using projective adaptive resonance theory as a gene filtering method Bioinformatics, January 15, 2005; 21(2): 179 - 186. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Kim, H. J. Jeong, M. Y. Seo, S. C. Kim, G. Cho, C. H. Park, T. S. Kim, K. H. Park, H. C. Chung, and S. Y. Rha Determination of Genes Related to Gastrointestinal Tract Origin Cancer Cells Using a cDNA Microarray Clin. Cancer Res., January 1, 2005; 11(1): 79 - 86. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Tamoto, M. Tada, K. Murakawa, M. Takada, G. Shindo, K.-i. Teramoto, A. Matsunaga, K. Komuro, M. Kanai, A. Kawakami, et al. Gene-Expression Profile Changes Correlated with Tumor Progression and Lymph Node Metastasis in Esophageal Cancer Clin. Cancer Res., June 1, 2004; 10(11): 3629 - 3638. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Dahlberg, L. F. Ferrin, S. M. Grindle, C. M. Nelson, C. D. Hoang, and B. Jacobson Gene expression profiles in esophageal adenocarcinoma Ann. Thorac. Surg., March 1, 2004; 77(3): 1008 - 1015. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. T. McManus, A. Olaru, and S. J. Meltzer Biomarkers of Esophageal Adenocarcinoma and Barrett's Esophagus Cancer Res., March 1, 2004; 64(5): 1561 - 1569. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Selaru, J. Yin, A. Olaru, Y. Mori, Y. Xu, S. H. Epstein, F. Sato, E. Deacu, S. Wang, A. Sterian, et al. An Unsupervised Approach to Identify Molecular Phenotypic Components Influencing Breast Cancer Features Cancer Res., March 1, 2004; 64(5): 1584 - 1588. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Gunther, D. J. Stone, R. W. Gerwien, P. Bento, and M. P. Heyes Prediction of clinical drug efficacy by classification of drug-induced genomic expression profiles in vitro PNAS, August 5, 2003; 100(16): 9608 - 9613. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Mori, F. M. Selaru, F. Sato, J. Yin, L. A. Simms, Y. Xu, A. Olaru, E. Deacu, S. Wang, J. M. Taylor, et al. The Impact of Microsatellite Instability on the Molecular Phenotype of Colorectal Tumors Cancer Res., August 1, 2003; 63(15): 4577 - 4582. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Su, N. Hu, J. Shih, Y. Hu, Q.-H. Wang, E. Y. Chuang, M. J. Roth, C. Wang, A. M. Goldstein, T. Ding, et al. Gene Expression Analysis of Esophageal Squamous Cell Carcinoma Reveals Consistent Molecular Profiles Related to a Family History of Upper Gastrointestinal Cancer Cancer Res., July 15, 2003; 63(14): 3872 - 3876. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Hansel, A. Rahman, M. Hidalgo, P. J. Thuluvath, K. D. Lillemoe, R. Shulick, J.-L. Ku, J.-G. Park, K. Miyazaki, R. Ashfaq, et al. Identification of Novel Cellular Targets in Biliary Tract Cancers Using Global Gene Expression Technology Am. J. Pathol., July 1, 2003; 163(1): 217 - 229. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C.W. Poon, T.-T. Yip, A. T.C. Chan, C. Yip, V. Yip, T. S.K. Mok, C. C.Y. Lee, T. W.T. Leung, S. K.W. Ho, and P. J. Johnson Comprehensive Proteomic Profiling Identifies Serum Proteomic Signatures for Detection of Hepatocellular Carcinoma and Its Subtypes Clin. Chem., May 1, 2003; 49(5): 752 - 760. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Lippman and W. K. Hong Cancer Prevention Science and Practice Cancer Res., September 15, 2002; 62(18): 5119 - 5125. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |